Prothrombin structure: Unanticipated features and opportunities

Expert Review of Proteomics

Volumn 11, Issue 6, 2014, Pages 653-655

  Pozzi, Nicola ^a   Di Cera, Enrico ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

blood coagulation; drug design; protease; prothrombin; structural biology

Indexed keywords

MEIZOTHROMBIN; PHOSPHOLIPID; PROTHROMBIN;

BLEEDING; CRYSTAL STRUCTURE; ENERGY TRANSFER; GENE MUTATION; HUMAN; PROTEIN STRUCTURE; REVIEW; CHEMISTRY; GENETICS; MUTATION; PROTEIN TERTIARY STRUCTURE;

HUMANS; MUTATION; PROTEIN STRUCTURE, TERTIARY; PROTHROMBIN;

EID: 84910673536     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/14789450.2014.971763     Document Type: Review

References (30)

1. Butenas S, van't Veer C, Mann KG. "Normal" thrombin generation. Blood 1999;94:2169-78
2. Lancellotti S, Basso M, De Cristofaro R. Congenital prothrombin deficiency: an update. Semin Thromb Hemost 2013;39:596-606
3. Sun WY, Witte DP, Degen JL, et al. Prothrombin deficiency results in embryonic and neonatal lethality in mice. Proc Natl Acad Sci USA 1998;95:7597-602
4. Xue J, Wu Q, Westfield LA, et al. Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice. Proc Natl Acad Sci USA 1998;95:7603-7
5. Huang YC, Wu YR, Tseng MY, et al. Increased prothrombin, apolipoprotein A-IV, and haptoglobin in the cerebrospinal fluid of patients with Huntington's disease. PLoS One 2011;6:e15809
6. Sciascia S, Sanna G, Murru V, et al. Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review. Thromb Haemost 2014;111:354-64
7. Haynes LM, Bouchard BA, Tracy PB, et al. Prothrombin activation by platelet-associated prothrombinase proceeds through the prethrombin-2 pathway via a concerted mechanism. J Biol Chem 2012;287:38647-55
8. Tans G, Janssen-Claessen T, Hemker HC, et al. Meizothrombin formation during factor Xa-catalyzed prothrombin activation. Formation in a purified system and in plasma. J Biol Chem 1991;266:21864-73
9. Brufatto N, Nesheim ME. Analysis of the kinetics of prothrombin activation and evidence that two equilibrating forms of prothrombinase are involved in the process. J Biol Chem 2003;278:6755-64
10. Lee CJ, Wu S, Eun C, et al. A revisit to the one form kinetic model of prothrombinase. Biophys Chem 2010;149:28-33
11. Orcutt SJ, Krishnaswamy S. Binding of substrate in two conformations to human prothrombinase drives consecutive cleavage at two sites in prothrombin. J Biol Chem 2004;279:54927-36
12. Rosing J, Tans G, Govers-Riemslag JW, et al. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem 1980;255:274-83
13. Bukys MA, Orban T, Kim PY, et al. The interaction of fragment 1 of prothrombin with the membrane surface is a prerequisite for optimum expression of factor Va cofactor activity within prothrombinase. Thromb Haemost 2008;99:511-22
14. Bradford HN, Orcutt SJ, Krishnaswamy S. Membrane binding by prothrombin mediates its constrained presentation to prothrombinase for cleavage. J Biol Chem 2013;288:27789-800
15. Bianchini EP, Orcutt SJ, Panizzi P, et al. Ratcheting of the substrate from the zymogen to proteinase conformations directs the sequential cleavage of prothrombin by prothrombinase. Proc Natl Acad Sci USA 2005;102:10099-104
16. Deguchi H, Takeya H, Gabazza EC, et al. Prothrombin kringle 1 domain interacts with factor Va during the assembly of prothrombinase complex. Biochem J 1997; 321(Pt 3):729-35
17. Kotkow KJ, Deitcher SR, Furie B, et al. The second kringle domain of prothrombin promotes factor Va-mediated prothrombin activation by prothrombinase. J Biol Chem 1995;270:4551-7
18. Yegneswaran S, Mesters RM, Fernandez JA, et al. Prothrombin residues 473-487 contribute to factor Va binding in the prothrombinase complex. J Biol Chem 2004;279:49019-25
19. Chen L, Yang L, Rezaie AR. Proexosite-1 on prothrombin is a factor Va-dependent recognition site for the prothrombinase complex. J Biol Chem 2003;278:27564-9
20. Taneda H, Andoh K, Nishioka J, et al. Blood coagulation factor Xa interacts with a linear sequence of the kringle 2 domain of prothrombin. J Biochem 1994;116:589-97
21. Yegneswaran S, Mesters RM, Griffin JH. Identification of distinct sequences in human blood coagulation factor Xa and prothrombin essential for substrate and cofactor recognition in the prothrombinase complex. J Biol Chem 2003;278:33312-18
22. Harlos K, Holland SK, Boys CW, et al. Vitamin K-dependent blood coagulation proteins form hetero-dimers. Nature 1987;330:82-4
23. Lechtenberg BC, Murray-Rust TA, Johnson DJ, et al. Crystal structure of the prothrombinase complex from the venom of Pseudonaja textilis. Blood 2013;122:2777-83
24. Pozzi N, Chen Z, Gohara DW, et al. Crystal structure of prothrombin reveals conformational flexibility and mechanism of activation. J Biol Chem 2013;288:22734-44
25. Pozzi N, Chen Z, Pelc LA, et al. The linker connecting the two kringles plays a key role in prothrombin activation. Proc Natl Acad Sci USA 2014;111:7630-5
26. Degen SJ, Davie EW. Nucleotide sequence of the gene for human prothrombin. Biochemistry 1987;26:6165-77
27. Kulkarni B, Kanakia S, Ghosh K, et al. Prothrombin Mumbai causes severe prothrombin deficiency due to a novel Cys90Ser mutation. Ann Hematol 2012;91: 1667-8
28. Lefkowitz JB, Weller A, Nuss R, et al. A common mutation, Arg457-Gln, links prothrombin deficiencies in the Puerto Rican population. J Thromb Haemost 2003;1:2381-8
29. Papaconstantinou ME, Bah A, Di Cera E. Role of the chain in thrombin function. Cell Mol Life Sci 2008;65:1943-7
30. Lefkowitz JB, Haver T, Clarke S, et al. The prothrombin Denver patient has two different prothrombin point mutations resulting in Glu-300-Lys and Glu-309-Lys substitutions. Br J Haematol 2000;108:182-7